South Africa’s East Coast beaches to remain open for holidays despite rising COVID-19 cases

By CGTN Africa Beaches in South Africa’s east coast will remain open as the winter school holidays approach despite an increase in COVID-19 infections in the country. According to local publication News24, Premier Sihle Zikalala, during a briefing on Sunday, expressed concern over the upcoming holiday season, but maintained that the East Coast would welcome all holidaymakers,…

Posted on

Soaring e-waste affects health of millions of children, WHO warns

By Halligan Agade Effective and binding action is urgently required to protect the millions of children, adolescents and expectant mothers globally whose health is jeopardized by the informal processing of discarded electrical or electronic devices according to a new ground-breaking report from the World Health Organization: Children and Digital Dumpsites. ”With mounting volumes of production and disposal,…

Africa’s Rising Covid-19 Cases ‘Especially Concerning,’ WHO Says

By Halligan Agade Rising COVID-19 cases in Africa are “especially concerning” because the region has the least amount of access to vaccines, diagnostics and oxygen, said World Health Organization Director-General Tedros Adhanom Ghebreyesus. Together with the spread of more transmissible variants this increases the continent’s mortality rate among critically ill COVID-19 patients, he told reporters in…

Zimbabwe raises alarm over increased wildlife attacks

By Halligan Agade Overpopulation of elephants and other surges in wildlife numbers is increasing the chances of human-animal contact and raises the chances that more people will be killed or injured by the animals, warns the Zimbabwe Parks and Wildlife Management Authority (Zimparks). Zimparks spokesperson Mr Tinashe Farawo recently said due to overpopulation of the elephants,…

Novavax says its COVID-19 vaccine is 90.4% effective

By Grace Kuria Novavax has on Monday announced that its COVID-19 vaccine is more than 90% effective against COVID-19. A statement issued by Novavax showed that, NVX-CoV2373, (Novavax’s recombinant nanoparticle protein-based COVID-19 vaccine), demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall. The results were met through a study which enrolled 29,960 participants across…